Patients STLAM4, STLAM5, and STLAM7 did not carry the FGFR4 variant but exhibited cystic lung disease in the absence of detectable systemic TSC2 mutations (Supplementary Table 1). This evidence concerns the gene TSC2 and cystic disease of lung.